Work

Correction: Schmitz et al. The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies. Biomedicines 2025, 13, 1319

Year: 2025

Type: erratum

Abstract: Correction [...]

Source: Biomedicines

DOI: 10.3390/biomedicines13112627

Authors: Alexa E. Schmitz, Shirsa Udgata, Katherine A. Johnson, Dustin A. Deming

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,137

Funders: V Foundation for Cancer Research, University of Wisconsin Carbone Cancer Center

Awards: G1443691388, G1490938784, G4004214011, G4520245238, G491591111, G6430838873

OpenAlex ID: W4415616512

Cites: 1

Cited by:

Related to: 10